262 related articles for article (PubMed ID: 25339768)
21. Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity.
Anstett K; Fusco R; Cutillas V; Mesplède T; Wainberg MA
J Virol; 2015 Oct; 89(20):10482-8. PubMed ID: 26246578
[TBL] [Abstract][Full Text] [Related]
22. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
24. Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics.
Nakahara K; Wakasa-Morimoto C; Kobayashi M; Miki S; Noshi T; Seki T; Kanamori-Koyama M; Kawauchi S; Suyama A; Fujishita T; Yoshinaga T; Garvey EP; Johns BA; Foster SA; Underwood MR; Sato A; Fujiwara T
Antiviral Res; 2009 Feb; 81(2):141-6. PubMed ID: 19027039
[TBL] [Abstract][Full Text] [Related]
25. Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.
Fontana J; Keller PW; Urano E; Ablan SD; Steven AC; Freed EO
J Virol; 2016 Jan; 90(2):972-8. PubMed ID: 26537676
[TBL] [Abstract][Full Text] [Related]
26. Substitutions at amino acid positions 143, 148, and 155 of HIV-1 integrase define distinct genetic barriers to raltegravir resistance in vivo.
Fransen S; Gupta S; Frantzell A; Petropoulos CJ; Huang W
J Virol; 2012 Jul; 86(13):7249-55. PubMed ID: 22553340
[TBL] [Abstract][Full Text] [Related]
27. A homology model of HIV-1 integrase and analysis of mutations designed to test the model.
Johnson BC; Métifiot M; Ferris A; Pommier Y; Hughes SH
J Mol Biol; 2013 Jun; 425(12):2133-46. PubMed ID: 23542006
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor.
Bar-Magen T; Sloan RD; Donahue DA; Kuhl BD; Zabeida A; Xu H; Oliveira M; Hazuda DJ; Wainberg MA
J Virol; 2010 Sep; 84(18):9210-6. PubMed ID: 20610719
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis.
Kessl JJ; Kutluay SB; Townsend D; Rebensburg S; Slaughter A; Larue RC; Shkriabai N; Bakouche N; Fuchs JR; Bieniasz PD; Kvaratskhelia M
Cell; 2016 Aug; 166(5):1257-1268.e12. PubMed ID: 27565348
[TBL] [Abstract][Full Text] [Related]
30. A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.
Chunduri H; Rimland D; Nurpeisov V; Crumpacker CS; Sharma PL
Virol J; 2011 Jan; 8():33. PubMed ID: 21255423
[TBL] [Abstract][Full Text] [Related]
31. Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
Malet I; Subra F; Charpentier C; Collin G; Descamps D; Calvez V; Marcelin AG; Delelis O
mBio; 2017 Sep; 8(5):. PubMed ID: 28951475
[TBL] [Abstract][Full Text] [Related]
32. The HIV-1 integrase mutant R263A/K264A is 2-fold defective for TRN-SR2 binding and viral nuclear import.
De Houwer S; Demeulemeester J; Thys W; Rocha S; Dirix L; Gijsbers R; Christ F; Debyser Z
J Biol Chem; 2014 Sep; 289(36):25351-61. PubMed ID: 25063804
[TBL] [Abstract][Full Text] [Related]
33. Characterization of HIV-1 integrase N-terminal mutant viruses.
Lloyd AG; Ng YS; Muesing MA; Simon V; Mulder LC
Virology; 2007 Mar; 360(1):129-35. PubMed ID: 17109911
[TBL] [Abstract][Full Text] [Related]
34. Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase.
Takahata T; Takeda E; Tobiume M; Tokunaga K; Yokoyama M; Huang YL; Hasegawa A; Shioda T; Sato H; Kannagi M; Masuda T
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795445
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
36. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
37. Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.
Eschbach JE; Elliott JL; Li W; Zadrozny KK; Davis K; Mohammed SJ; Lawson DQ; Pornillos O; Engelman AN; Kutluay SB
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115869
[TBL] [Abstract][Full Text] [Related]
38. The N-end rule and retroviral infection: no effect on integrase.
Boso G; Tasaki T; Kwon YT; Somia NV
Virol J; 2013 Jul; 10():233. PubMed ID: 23849394
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 B-subtype capsid protein: a characterization of amino acid's conservation and its significant association with integrase signatures.
Dimonte S; Babakir-Mina M; Aquaro S
Virus Genes; 2014 Jun; 48(3):429-37. PubMed ID: 24474329
[TBL] [Abstract][Full Text] [Related]
40. Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation.
Nakamura T; Masuda T; Goto T; Sano K; Nakai M; Harada S
Biochem Biophys Res Commun; 1997 Oct; 239(3):715-22. PubMed ID: 9367835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
